Novavax (NVAX) to Report Q3 Earnings: What’s in the Cards? Posted byZacks Equity Research November 1, 2021 Leave a comment on Novavax (NVAX) to Report Q3 Earnings: What’s in the Cards? On Novavax’s (NVAX) upcoming third-quarter earnings call, investor focus is likely to be on the company’s progress with its COVID-19 vaccine candidate NVX-CoV2373.